Industry News
Fresh Science competition closes this week
Nominations for Fresh Science, the national competition that helps early-career researchers find, and then share, their stories of discovery, close this week. [ + ]
UNSW to house Australia's first quantum computing company
Silicon Quantum Computing, which holds the distinction of being Australia's first harware quantum computing company, has been launched at the University of New South Wales (UNSW). [ + ]
Boehringer Ingelheim initiates Phase IIa study of liver disease drug
Boehringer Ingelheim has initiated a European and North American Phase IIa trial in non-alcoholic steatohepatitis (NASH) of investigational drug candidate BI 1467335, acquired from fellow pharma company Pharmaxis in May 2015. [ + ]
Clarivate Analytics selected as ERA citation provider
The Australian Research Council has announced its selection of Clarivate Analytics to provide citation information for the 2018 round of Excellence in Research for Australia (ERA), Australia's national research evaluation framework. [ + ]
Stemina prepares to launch autism diagnostic product
As it gears up for the launch of its autism diagnostic test panel, US metabolomics company Stemina Biomarker Discovery has announced the appointment of Dr Heiner Dreismann to its board of directors. [ + ]
Immune system can be modulated by manipulating metabolism
Austrian researchers have revealed that such an excessive immune response can be modulated by targeted manipulation of sugar metabolism. [ + ]
QIAGEN and Clinical Genomics partner on liquid biopsy for colorectal cancer
QIAGEN has announced the implementation of the PAXgene Blood ccfDNA Tube with Clinical Genomics' Colvera colorectal cancer (CRC) recurrence assay, enabling blood to be drawn and stored for several days before testing. [ + ]
'Stiffer' blood vessels may increase risk of heart attack
Research led by Macquarie University has found that blood vessel 'stiffness', or distensibility, is an important determinant of blood flow, and may play a role in influencing the fate of Australians living with coronary heart disease. [ + ]
Combating superbug resistance with phage therapy
Researchers have shown that bacteriophage therapy can be used successfully to treat systemic, multidrug-resistant bacterial infections. [ + ]
Perth clinical research company using electronic trial data capture
Perth-based research company Linear Clinical Research is using cloud-based technology to record data on its patients and participants involved in a clinical trial. [ + ]
Immunotherapy for peanut allergy proves effective four years on
A treatment for deadly peanut allergy has been found to show long-lasting effects, providing what is claimed to be the strongest evidence yet that a cure may be possible for peanut allergy. [ + ]
Harry Butler Institute to promote conservation and environmental management
Murdoch University joined global energy producer Chevron for the official launch of the Harry Butler Institute, set to shape the next generation of leaders in conservation and environmental management. [ + ]
Young Tall Poppies recognised during National Science Week
Nine outstanding young researchers from NSW have been recognised with Young Tall Poppy Science Awards as part of the Sydney Science Festival and National Science Week. [ + ]
3D printing stem cells to create living tissues
UK scientists have developed a method to 3D print stem cells to form complex living 3D structures — a breakthrough that could potentially revolutionise regenerative medicine. [ + ]
Adherium sells its 100,000th Smartinhaler
Digital health company Adherium is celebrating a significant milestone, having recently manufactured and sold its 100,000th Smartinhaler. [ + ]
